FDA clears the VySpine VySpan posterior cervical thoracic system.
Federal Register notice: FDA announces that CDER, CBER, CDRH and Center for Tobacco Products have modified their organizational structures.
FDA clears a Meridian Bioscience 510(k) for the Curian Campy assay, a rapid, qualitative fluorescent immunoassay for detecting Campylobacter-specific ...
Attorney Faraz Siddiqui explains provisions of the revised PhRMA Code on company interactions with healthcare practitioners and why companies may want...
FDA removes a Spero Therapeutics clinical hold on a Phase 2 trial of SPR720, an investigational oral product being developed for nontuberculous mycoba...
FDA says it has temporarily postponed all face-to-face domestic and foreign inspectional work except for mission-critical inspections because of safet...
FDA releases an FDA-483 with seven observations from an inspection at Union, NJ-based Ideal Pharmacy.
Federal Register notice: FDA announces that its Office of the Chief Scientist has modified its organizational structure.